Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Buys $27,580.00 in Stock
MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Get Free Report) CEO Seth Lederman acquired 2,000 shares of the stock in a transaction on Thursday, August 27th. The stock was bought at an average cost of $13.79 per share, with a total value of $27,580.00. Following the completion of the transaction, the chief executive officer owned 11,005 shares in the company, valued at $151,758.95. This trade represents a 22.21% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
NASDAQ:TNXP